SynCardia Systems yesterday registered for an initial public offering worth up to $40 million, making it the 2nd medical device company in as many weeks to file for an IPO.
SynCardia, which makes an artificial heart system designed to replace the functions of both the left and right ventricles and all 4 heart valves, said it plans to list on the NASDAQ exchange under the “TAHT” symbol. The total artificial heart SynCardia calls TAH-t is on the market in the U.S., European Union and Canada for use as a bridge to heart transplantation in patients with advanced heart failure.
Help employers find you! Check out all the jobs and post your resume.
